Physician
Mercy Specialty Clinic
Mercy Specialty Clinic was paid $6.61M by Medicaid between Jul 2019 and Dec 2024, across 125 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 32% of everything it billed.
33Billing provider infoMERCY SPECIALTY CLINIC
CLINTON, IA 52732
CLINTON, IA 52732
33aNPI1275197998assigned 04/29/2019
33bProvider typeFamily Medicine Physician
28Total paid$6.61M
24GClaims226,107
24DCodes billed125
24AFirst – last monthJul 2019 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Iowa
Rank by total paid#14 of 275
Median peer was paid$69K
This provider vs. median96×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 27,274 | $652K | |
| 2020 | 39,737 | $1.17M | |
| 2021 | 47,735 | $1.37M | |
| 2022 | 50,604 | $1.60M | |
| 2023 | 31,235 | $901K | |
| 2024incomplete | 29,522 | $918K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 32% | 46,302 | 42,504 | $2.08M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 36,591 | 33,941 | $1.13M |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 5.9% | 3,001 | 2,874 | $390K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.4% | 8,000 | 7,678 | $358K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 4.3% | 5,783 | 5,646 | $287K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.3% | 4,241 | 3,745 | $287K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.1% | 2,710 | 2,633 | $204K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3.0% | 3,705 | 3,555 | $198K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.0% | 1,259 | 1,222 | $134K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.9% | 1,284 | 1,258 | $124K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.8% | 5,252 | 5,108 | $120K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 12,118 | 11,542 | $117K |
113 more codes
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.6% | 8,870 | $109K |
| 99203 | Doctor's office visit, new patient (routine) | 1.6% | 2,359 | $107K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.2% | 1,066 | $82K |
| 87631 | 1.2% | 640 | $77K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.1% | 10,623 | $74K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,114 | $62K |
| 36415 | Collection of venous blood by venipuncture | <1% | 20,325 | $54K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 532 | $46K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,339 | $40K |
| 80050 | General health panel | <1% | 781 | $35K |
| 80053 | Comprehensive metabolic panel | <1% | 2,620 | $31K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,883 | $28K |
| 81001 | <1% | 6,051 | $25K | |
| 98928 | <1% | 491 | $22K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 328 | $21K |
| 80061 | Lipid panel | <1% | 1,383 | $21K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,425 | $21K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 369 | $20K |
| 90686 | <1% | 2,692 | $17K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 207 | $14K |
| 20610 | <1% | 407 | $14K | |
| 86738 | <1% | 765 | $13K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 231 | $12K |
| 11721 | <1% | 1,420 | $11K | |
| 83655 | <1% | 624 | $10K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 994 | $10K |
| 84439 | <1% | 1,007 | $9K | |
| 99460 | <1% | 150 | $9K | |
| 90474 | <1% | 1,246 | $8K | |
| 94060 | <1% | 286 | $8K | |
| 0012A | <1% | 200 | $8K | |
| 87807 | <1% | 471 | $8K | |
| 93000 | <1% | 561 | $8K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 136 | $7K |
| 95806 | <1% | 86 | $7K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 91 | $7K |
| 0011A | <1% | 212 | $7K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 172 | $7K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 273 | $6K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 147 | $6K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 679 | $6K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 73 | $5K |
| 93016 | <1% | 276 | $5K | |
| 80076 | <1% | 441 | $5K | |
| 84703 | <1% | 422 | $4K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 79 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 79 | $4K |
| 99205 | Prolong outpt/office vis | <1% | 38 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 320 | $4K |
| 93018 | <1% | 295 | $3K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 63 | $3K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 458 | $3K |
| 83721 | <1% | 292 | $3K | |
| 90710 | <1% | 476 | $2K | |
| 90651 | <1% | 223 | $2K | |
| 83718 | <1% | 251 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 111 | $2K |
| 80047 | <1% | 178 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 47 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 76 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 573 | $2K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 186 | $2K |
| 84478 | <1% | 250 | $2K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 49 | $2K |
| 81002 | <1% | 487 | $1K | |
| 91320 | <1% | 17 | $1K | |
| 73630 | <1% | 198 | $1K | |
| 90734 | <1% | 209 | $1K | |
| 82565 | <1% | 192 | $1K | |
| 90698 | <1% | 1,768 | $1K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 13 | $1K |
| 99462 | <1% | 32 | $1K | |
| 90696 | <1% | 190 | $806.40 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 16 | $791.34 |
| 99173 | <1% | 405 | $743.39 | |
| 90670 | <1% | 2,437 | $708.78 | |
| 87081 | <1% | 110 | $669.17 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 271 | $663.67 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 16 | $628.53 |
| 90633 | <1% | 823 | $567.21 | |
| 90715 | <1% | 65 | $562.28 | |
| 90480 | <1% | 17 | $493.20 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 67 | $473.28 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12 | $421.85 |
| 90461 | <1% | 18 | $418.46 | |
| 97597 | <1% | 77 | $378.62 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 40 | $336.75 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | $277.32 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 24 | $267.35 |
| 90680 | <1% | 1,266 | $245.21 | |
| 93244 | <1% | 14 | $231.72 | |
| 92504 | <1% | 46 | $204.50 | |
| 85027 | <1% | 33 | $196.98 | |
| 94250 | <1% | 27 | $183.48 | |
| 99307 | <1% | 29 | $141.04 | |
| 82950 | <1% | 23 | $121.71 | |
| 73564 | <1% | 13 | $100.47 | |
| 96161 | <1% | 13 | $90.89 | |
| 90661 | <1% | 76 | $87.24 | |
| 90744 | <1% | 692 | $53.99 | |
| 90648 | <1% | 747 | $48.10 | |
| 90677 | <1% | 314 | $1.17 | |
| 90647 | <1% | 49 | $0.05 | |
| 90723 | <1% | 519 | $0.05 | |
| 90620 | <1% | 17 | $0.01 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 1,432 | $0.00 |
| 1101F | 0% | 568 | $0.00 | |
| 91301 | 0% | 410 | $0.00 | |
| 1111F | 0% | 47 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 174 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 1,102 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 206 | $0.00 |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWOOD, MEILLISSA (COO/CNO)